Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 8:12:1615561.
doi: 10.3389/fmed.2025.1615561. eCollection 2025.

Frontal QRS-T angle remains unchanged in fibromyalgia: a cross-sectional study with implications for routine ECG screening

Affiliations

Frontal QRS-T angle remains unchanged in fibromyalgia: a cross-sectional study with implications for routine ECG screening

Hüseyin Tezcan et al. Front Med (Lausanne). .

Abstract

Aim: Fibromyalgia syndrome (FMS) is a chronic condition characterized by widespread pain and associated with systemic diseases. Although autonomic dysfunction in FMS may predispose to cardiac arrhythmias, its impact on cardiac parameters, such as the frontal QRS-T [f(QRS-T)] angle, remains unclear. This study aimed to investigate the f(QRS-T) angle in FMS patients compared to healthy controls.

Methods: A total of 75 FMS patients and 75 healthy controls were included in this cross-sectional study. Disease severity was assessed using the Fibromyalgia Impact Questionnaire (FIQ). The f(QRS-T) angle was calculated from 12-lead electrocardiograms by a blinded cardiologist. Associations between the f(QRS-T) angle, FIQ scores, and duloxetine use were analyzed using appropriate statistical methods.

Results: No significant differences in the f(QRS-T) angle were observed between FMS patients and controls (p = 0.973). Additionally, no correlation was found between FIQ scores and the f(QRS-T) angle (p = 0.725). Subgroup analysis revealed no significant differences in the f(QRS-T) angle between FMS patients using duloxetine and those not using it (p = 0.503).

Conclusion: Contrary to concerns about subclinical cardiac involvement in FMS, our findings reveal no significant alterations in the f(QRS-T) angle among FMS patients. Moreover, disease severity and duloxetine use do not influence this parameter. These results challenge the assumption of clinically relevant cardiac dysregulation in FMS and suggest that routine ECG screening may not be necessary for patients with FMS. Nonetheless, longitudinal studies are warranted to fully clarify the long-term cardiac risk in this population.

Keywords: arrhythmia; autonomic dysfunction; cardiac screening; chronic pain; duloxetine; electrocardiogram; fibromyalgia; frontal QRS-T angle.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

ECG tracing showing multiple leads with heart rate of 83 beats per minute. Measurements include a PR interval of 186 milliseconds, QRS duration of 72 milliseconds, and QT interval of 407 milliseconds. Regular sinus rhythm with consistent waveform patterns is visible across all leads.
FIGURE 1
A standard 12-lead electrocardiogram (ECG) showing sinus rhythm with a heart rate of 83 bpm. The QRS axis is 72° and the T axis is 12°, resulting in a frontal QRS-T angle of 60°, calculated as the absolute difference between the QRS and T axes (|QRS axis–T axis|).
Flowchart detailing participant inclusion and exclusion in a study. Initially, 171 participants consented: 84 FMS patients and 87 controls. In FMS patients, 9 were excluded due to incomplete ECG (5), hypertension (3), or withdrew consent (1). In controls, 12 were excluded for incomplete ECG (6), hypertension (3), or withdrew consent (3). Finally, 75 participants were analyzed in both FMS and control groups.
FIGURE 2
Participant-flow diagram.
Box plot comparing frontal QRS-T angle in degrees across four groups: Controls, FMS, FMS with Duloxetine, and FMS without Duloxetine. Each plot shows median, quartiles, and outliers, with FMS + Duloxetine having a noticeably lower median.
FIGURE 3
Frontal QRS–T angle in healthy controls (n = 75), fibromyalgia patients overall (FMS, n = 75), and fibromyalgia syndrome (FMS) sub-groups using (n = 19) or not using (n = 56) duloxetine. Boxes represent the inter-quartile range (IQR); horizontal lines are medians; whiskers reach the most extreme values within 1.5 × IQR; filled circles denote statistical outliers. Mann–Whitney U tests: FMS vs. controls, p = 0.973; FMS+ vs. –duloxetine, p = 0.503.

Similar articles

References

    1. Clauw D. Fibromyalgia: A clinical review. JAMA. (2014) 311:1547–55. 10.1001/jama.2014.3266 - DOI - PubMed
    1. Bair M, Krebs E. Fibromyalgia. Ann Intern Med. (2020) 172:ITC33–48. 10.7326/AITC202003030 - DOI - PubMed
    1. Arnold L, Bennett R, Crofford L, Dean L, Clauw D, Goldenberg D, et al. AAPT diagnostic criteria for fibromyalgia. J Pain. (2019) 20:611–28. 10.1016/j.jpain.2018.10.008 - DOI - PubMed
    1. Oehler A, Feldman T, Henrikson C, Tereshchenko L. QRS-T angle: A review. Ann Noninvasive Electrocardiol. (2014) 19:534–42. 10.1111/anec.12159 - DOI - PMC - PubMed
    1. Jogu H, O’Neal W, Broughton S, Shah A, Zhang Z, Soliman E. Frontal QRS-T angle and the risk of atrial fibrillation in the elderly. Ann Noninvasive Electrocardiol. (2017) 22:e12388. 10.1111/anec.12388 - DOI - PMC - PubMed

LinkOut - more resources